InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,841.76
(
0.46%
)
US TECH 100
19,665.50
(
0.16%
)
Dow Jones
43,071.01
(
0.77%
)
Brent Oil
74.05
(
-0.57%
)
Bitcoin
67,838.85
(
1.24%
)
Post# of 19309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 47
Posts 4723
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: None

Tuesday, 10/31/2006 12:57:22 PM

Tuesday, October 31, 2006 12:57:22 PM

Post# of 19309
EMIS PR got me thinking about GTCB

There seems to be some effort to deliver larger macromolecules via the GI route. It stands to reason very high doses of biologics would be needed, as bioavailability will be very limited...perhaps this is another area where GTCB's capability to produce high volume of drug becomes more advantageous over cell culture even for drugs for which parenteral supplies are plentiful

jsut thinking out loud
disclaimer: not invested in (nor interested in EMIS)
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up